Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Vavra

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1992
[Fallopian tube cancer--an Austrian multicenter study]M Klein, A Rosen, N Vavra, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancerS Rasoul-Rockenschaub, C C Zielinski, E Kubista, et al.
British Journal of Cancer|May 1, 1993
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancerA Rosen, P Sevelda, M Klein, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1993
[Primary fallopian tube cancer--an Austrian multicenter study]A Rosen, M Klein, M Lahousen, et al.
Gynecologic Oncology|June 1, 1994
Prognostic factors in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube CarcinomaA C Rosen, A Reiner, M Klein, et al.
British Journal of Cancer|March 1, 1994
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancerA C Rosen, P Sevelda, M Klein, et al.
Anticancer Research|March 1, 1996
Influence of delayed diagnosis on established prognostic factors in endometrial cancerA Obermair, E Hanzal, I Schreiner-Frech, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factorH Stöger, H Samonigg, M Krainer, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1992
[Fallopian tube cancer--an Austrian multicenter study]M Klein, A Rosen, N Vavra, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1989
Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancerS Rasoul-Rockenschaub, C C Zielinski, E Kubista, et al.
British Journal of Cancer|May 1, 1993
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancerA Rosen, P Sevelda, M Klein, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1993
[Primary fallopian tube cancer--an Austrian multicenter study]A Rosen, M Klein, M Lahousen, et al.
Gynecologic Oncology|June 1, 1994
Prognostic factors in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube CarcinomaA C Rosen, A Reiner, M Klein, et al.
British Journal of Cancer|March 1, 1994
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancerA C Rosen, P Sevelda, M Klein, et al.
Anticancer Research|March 1, 1996
Influence of delayed diagnosis on established prognostic factors in endometrial cancerA Obermair, E Hanzal, I Schreiner-Frech, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factorH Stöger, H Samonigg, M Krainer, et al.
Pageof 10